These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6132360)

  • 21. A murine model for type III tyrosinemia: lack of immunologically detectable 4-hydroxyphenylpyruvic acid dioxygenase enzyme protein in a novel mouse strain with hypertyrosinemia.
    Endo F; Katoh H; Yamamoto S; Matsuda I
    Am J Hum Genet; 1991 Apr; 48(4):704-9. PubMed ID: 2014797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosinaemia type III: immunochemical studies on 4-hydroxyphenylpyruvic acid dioxygenase and molecular cloning of cDNA for the enzyme.
    Endo F; Awata H; Tanoue A; Eda Y; Matsuda I
    J Inherit Metab Dis; 1991; 14(5):783-6. PubMed ID: 1779624
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative determination of enzyme activities in Fasciola hepatica and bovine liver].
    Sturm G; Hirschhäuser C; Zilliken F
    Hoppe Seylers Z Physiol Chem; 1969 Jun; 350(6):696-700. PubMed ID: 5799708
    [No Abstract]   [Full Text] [Related]  

  • 24. A new sulfur amino acid, named hawkinsin, identified in a baby with transient tyrosinemia and her mother.
    Niederwieser A; Matasovic A; Tippett P; Danks DM
    Clin Chim Acta; 1977 May; 76(3):345-56. PubMed ID: 858207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo correction with recombinant adenovirus of 4-hydroxyphenylpyruvic acid dioxygenase deficiencies in strain III mice.
    Kubo S; Kiwaki K; Awata H; Katoh H; Kanegae Y; Saito I; Yamamoto T; Miyazaki J; Matsuda I; Endo F
    Hum Gene Ther; 1997 Jan; 8(1):65-71. PubMed ID: 8989996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perinatal development of the tyrosine oxidizing system.
    Coufalik A; Monder C
    Biol Neonate; 1978; 34(3-4):161-6. PubMed ID: 32931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some biochemical effects of chloral hydrate in an infant with a tyrosinemia-like syndrome.
    Watts RW; Chalmers RA; Liberman MM; Lawson AM
    Pediatr Res; 1975 Dec; 9(12):875-8. PubMed ID: 1196703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary tyrosinemia type I--an overview.
    Kvittingen EA
    Scand J Clin Lab Invest Suppl; 1986; 184():27-34. PubMed ID: 3296130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the conversion of multiple forms of tyrosine aminotransferase in rat liver.
    Rodriguez JM; Pitot HC
    Arch Biochem Biophys; 1976 Nov; 177(1):185-95. PubMed ID: 11749
    [No Abstract]   [Full Text] [Related]  

  • 30. [Other abnormalities of tyrosine metabolism].
    Endo F
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):144-5. PubMed ID: 9590010
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic hypoxia: accumulation of tyrosine metabolites in hepatocytes at low pO2.
    Jones DP; Mason HS
    Biochem Biophys Res Commun; 1978 Feb; 80(3):477-83. PubMed ID: 24444
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of dietary threonine supplementation on tyrosine toxicity in the rat.
    Datta K; Ghosh JJ
    J Nutr; 1977 Sep; 107(9):1575-82. PubMed ID: 19567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune thyroiditis in a case of tyrosinaemia type III.
    D'Eufemia P; Giardini O; Cantani A; Martino F; Finocchiaro R
    J Inherit Metab Dis; 1992; 15(6):861-2. PubMed ID: 1293381
    [No Abstract]   [Full Text] [Related]  

  • 34. Liver enlargement and hepatoxicity: an investigation into the effects of several agents on rat liver enzyme activities.
    Platt DS; Cockrill BL
    Biochem Pharmacol; 1967 Dec; 16(12):2257-70. PubMed ID: 4294662
    [No Abstract]   [Full Text] [Related]  

  • 35. Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene (HPD) in patients with tyrosinemia type III.
    Rüetschi U; Cerone R; Pérez-Cerda C; Schiaffino MC; Standing S; Ugarte M; Holme E
    Hum Genet; 2000 Jun; 106(6):654-62. PubMed ID: 10942115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the regulation of tyrosine transaminase, glutamatic dehydrogenase and aspartic transaminase in Tetrahymena.
    Porter P; Blum JJ
    Exp Cell Res; 1973 Mar; 77(1):335-45. PubMed ID: 4144081
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparative analysis of the ontogenic development of rat liver sequential enzymes-tyrosine -ketoglutarate aminotransferase, p-hydroxyphenylpyruvate hydroxylase, and homogenitsate oxygenase.
    Goswami MN; Rosenberg AJ; Meury F
    Dev Biol; 1973 Jan; 30(1):129-36. PubMed ID: 4144568
    [No Abstract]   [Full Text] [Related]  

  • 38. [Measurement of the total activity of glutamate-oxaloacetic transaminase in liver homogenates].
    Schröckert WM; Bässler KH
    Clin Chim Acta; 1971 Jun; 33(1):55-60. PubMed ID: 5098015
    [No Abstract]   [Full Text] [Related]  

  • 39. Mechanism of allylisopropylacetamide-induced increase of delta-aminolevulinate synthetase in liver mitochondria. Effects of administration of glucose, cyclic AMP, and some hormones related to glucose metabolism.
    Kim HJ; Kikuchi G
    Arch Biochem Biophys; 1974 Sep; 164(1):293-304. PubMed ID: 4154726
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of a glucocorticoid on the concentrations of CoA and carnitine esters and on redox state in bovine liver.
    Baird GD; Heitzman RJ; Snoswell AM
    Eur J Biochem; 1972 Aug; 29(1):104-9. PubMed ID: 4343296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.